RWD in a COVID-19 World
COVID-19 has been linked to the development of other, non-respiratory diseases including heart attacks. Understanding this correlation requires real world [...]
Can User Guide for Biden Inform Drug Cost Policy?
Drug costs will be a point of policy for Biden’s administration. Although there are many theories and proposed solutions, reducing [...]
Tracking Costs of Common Drugs in the US Market
In a recent article, the authors discuss drug-pricing trends in medications. They restricted their study to brand-name medications used to [...]
Registration is Open for Asembia’s Specialty Pharmacy Summit
Register today for Asembia’s Specialty Pharmacy Summit. Earlybird rates are available through April 16th, 2021 for both member pharmacies and [...]
Are Budget Caps a Solution to Skyrocketing Health Costs?
Healthcare costs and access to health services continue to be major points of discussion. One proposed solution is that of [...]
NICE rejects MS drug Zeposia Citing Cost Concerns
Bristol Myers Squibb developed Zeoposia (ozanimod) for use in multiple sclerosis patients. NICE (National Institute for Health and Care Excellence) [...]
Positive Consequence of Senate Pharma Pricing Bill?
The Senate Finance Committee’s bill on drug pricing was co-authored and introduced by Chuck Grassley and Ron Wyden. The authors [...]
Are Authorized Generics a Solution to High Drug Costs?
In response to concerns over drug prices, some pharmaceutical companies have released authorized generics as alternatives to brand-name products. These [...]
What Will Happen to Novartis Cholesterol Drug?
Novartis drug inclisiran wasn’t reviewed on time by the FDA—largely because of COVID-19 travel restrictions. Now, the company seeks to [...]
Yes–Prescription Costs are Much Higher in the United States
According to a recent article, there are serious discrepancies in drug prices between the United States and many other countries. [...]
Article Highlights Healthcare Challenges for Biden
A recent publication highlights ongoing issues in healthcare, along with strategies for addressing these issues for the newly elected administration. [...]
Progress with Gene Therapies Requires Medicare Reform
Novel therapeutic approaches, although promising in the personalized medicine space, remain hampered by cost issues when it comes to Medicare [...]
Conversation with Aetion Chief Legal and Executive Officer Provides Insight
Lowell Schiller, J.D., now the Chief Legal and Executive Officer at Aetion, discussed his views on RWE, the FDA, and [...]
COVID-19 Prompts RWE Discussion
During the 2020 Aetion Summit, invited speaker Amy Abernathy, MD, PHD, was invited to give her perspective on real world [...]
Data Analytics Company Artemis Health Collects Employee Data
Artemis Health surveyed employees regarding their healthcare goals at hundreds of companies. Many employees rated focusing on their health as [...]
Understanding Machine Learning Tools that Will Impact Healthcare
Predictive machine learning tools are expected to help healthcare payers and providers make cost-effective choices. However, despite being powerful tools, [...]
New Robust Tool STaRT-RWE Brings Clarity
In a recent publication, Wang et al. discuss STaRT-RWE: a tool for reporting real world evidence data. This tool is [...]
Will Pharma Prices Increase Under Biden Administration?
Pharma companies are preparing for changes under the Biden administration, including in-depth discussions about drug pricing—for both new drugs and [...]
Pharma Companies Silently Raising Prices
Many pharmaceutical companies have been rapidly increasing prices of their drugs. In only one month of 2021, more drug prices [...]
$559 Million Saved in Medicare Costs by NAACOS
According to a recent NAACOS (the National Association of ACOs) report detailing Medicare savings, over $550 million was saved by [...]
ISMPP Takes Over MPIP Leadership
ISMPP revealed it would be taking over leadership responsibilities for MPIP (Medical Publishing Insights & Practices). MPIP has been an [...]
Can the Fauci Effect Lead to a Larger Pool of Health Care Workers?
In 2020, there were 18% more medical-school-ready applicants than in previous years. This higher number is due to several factors, [...]
Bayesian Models are Underused yet Powerful Tools
In a recent study, Cytel researchers discussed the benefits of Bayesian models. They’re a good choice for both single arm [...]
2021 Brings Changes for Payers and Providers
COVID-19 has broadly impacted the healthcare system. Many fee for service providers were forced to switch to value-based payments over [...]
Online Healthcare Pricing Information Unclear and Confusing
Healthcare systems and hospitals posted pricing information for their services beginning January 1st. However, consistency across hospital systems remains lacking. [...]